Fostera PRRS Swine Vaccine, Modified Live Virus, 100mL/50ds.
Zoetis - Fostera PRRS is a porcine reproductive and respiratory syndrome vaccine.
Fostera PRRS vaccine by Zoetis is a porcine reproductive and respiratory syndrome (PRRS) vaccine to be used in healthy, susceptible swine in PRRS virus-positive herds and can also be used on any seronegative pigs deemed at risk to exposure to PRRS.
FEATURES / BENEFITS
The vaccine has demonstrated a 19-week duration of immunity against reproductive disease has been demonstrated in swine vaccinated prebreeding while also producing a 26-week duration of immunity against respiratory disease.
Fostera PRRS vaccine provides comprehensive herd management of PRRSV by helping protect against both the respiratory and reproductive forms of the disease helping pigs get to market faster with improved average daily gain (ADG) in the face of a constant PRRS virus challenge.
Providing early protection (1-day of age claim) allowing for vaccination of piglets on the sow farm, Fostera PRRS vaccine helps deliver more live pigs by helping prevent reproductive disease caused by PRRSV.
Store at 2°-7°C. Do not freeze.
Not for use in boars of breeding age.
Use entire contents when first opened.
Burn containers and all unused contents.
Sterilized syringes and needles should be used to administer this vaccine.
Do not vaccinate within 21 days before slaughter.
Contains gentamicin as preservative.
As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended.
Fetal health risks associated with vaccination of pregnant animals with modified live vaccines cannot be unequivocally determined by clinical trials conducted for licensure. Management strategies based on vaccination of pregnant animals with modified live vaccines should be discussed with a veterinarian.
Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided.
Shake well and aseptically administer a single 2-mL dose intramuscularly to pigs 1 day of age or older.
Efficacy has not been demonstrated in seropositive piglets. In young pigs, re-vaccinate after maternally derived antibodies to PRRS have declined. Safety of this product has been demonstrated when sows or gilts are vaccinated prior to breeding or at any stage of pregnancy. Protection against reproductive disease, however, was demonstrated when animals were vaccinated 6 weeks prior to breeding.
Consult your veterinarian for appropriate use and timing of vaccination.